Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer

被引:8
作者
Chen, Linjiao [1 ]
Wang, Jie [1 ]
Liu, Qian [1 ]
机构
[1] First Hosp Jilin Univ, Dept Reprod Med, Dept Prenatal Genet, Changchun, Peoples R China
关键词
lncRNA; epigenetic; chemoresistance; ovarian cancer; cisplatin; paclitaxel; target; CISPLATIN RESISTANCE; PACLITAXEL RESISTANCE; DRUG-RESISTANCE; SUPPRESSES; KNOCKDOWN; PROMOTES; HOTAIR; CELLS; OVEREXPRESSION; PROLIFERATION;
D O I
10.3389/fcell.2022.999174
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Long noncoding RNAs (lncRNAs) have been characterized to play an essential role in ovarian tumorigenesis via controlling a variety of cellular processes, such as cell proliferation, invasion, apoptotic death, metastasis, cell cycle, migration, metabolism, immune evasion, and chemoresistance. The one obstacle for the therapeutic efficacy is due to the development of drug resistance in ovarian cancer patients. Therefore, in this review article, we describe the role of lncRNAs in chemoresistance in ovarian cancer. Moreover, we discuss the molecular mechanism of lncRNAs-involved drug resistance in ovarian cancer. We conclude that lncRNAs could be useful targets to overcome chemoresistance and improve therapeutic outcome in ovarian cancer patients.
引用
收藏
页数:10
相关论文
共 75 条
[1]   The Long Non-Coding RNA SNHG12 as a Mediator of Carboplatin Resistance in Ovarian Cancer via Epigenetic Mechanisms [J].
Abildgaard, Cecilie ;
do Canto, Luisa Matos ;
Rainho, Claudia Aparecida ;
Marchi, Fabio Albuquerque ;
Calanca, Naiade ;
Waldstrom, Marianne ;
Steffensen, Karina Dahl ;
Rogatto, Silvia Regina .
CANCERS, 2022, 14 (07)
[2]   Long Non-coding RNAs Involved in Resistance to Chemotherapy in Ovarian Cancer [J].
Abildgaard, Cecilie ;
Do Canto, Luisa M. ;
Steffensen, Karina D. ;
Rogatto, Silvia R. .
FRONTIERS IN ONCOLOGY, 2020, 9
[3]   Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway [J].
Bai, Lin ;
Wang, Aihua ;
Zhang, Yali ;
Xu, Xiaofeng ;
Zhang, Xiao .
EXPERIMENTAL CELL RESEARCH, 2018, 366 (02) :161-171
[4]   Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer [J].
Bai, Zhuanli ;
Wu, YinYing ;
Bai, Shuheng ;
Yan, Yanli ;
Kang, Haojing ;
Ma, Wen ;
Zhang, Jiangzhou ;
Gao, Ying ;
Hui, Beina ;
Ma, Hailin ;
Li, Rong ;
Zhang, Xiaozhi ;
Ren, Juan .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (13) :7479-7489
[5]   Long Intergenic Noncoding RNA00265 Enhances Cell Viability and Metastasis via Targeting miR-485-5p/USP22 Axis in Osteosarcoma [J].
Chen, Ting ;
Liu, Jinxin ;
Zhang, He ;
Li, Jiatong ;
Shang, Guanning .
FRONTIERS IN ONCOLOGY, 2022, 12
[6]   Unraveling diverse roles of noncoding RNAs in various human papillomavirus negative cancers [J].
Chen, Xin ;
Liu, Yi ;
Liu, Hejing ;
Wang, Zhi-wei ;
Zhu, Xueqiong .
PHARMACOLOGY & THERAPEUTICS, 2022, 238
[7]   Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway [J].
Chen, Ying ;
Li, Fangxuan ;
Li, Dan ;
Liu, Wenxin ;
Zhang, Lei .
CLINICAL IMMUNOLOGY, 2021, 227
[8]   Long non-coding RNA HOXA11-AS knockout inhibits proliferation and overcomes drug resistance in ovarian cancer [J].
Chen, Yuwei ;
Cui, Zhaolei ;
Wu, Qiaoling ;
Wang, Huihui ;
Xia, Hongmei ;
Sun, Yang .
BIOENGINEERED, 2022, 13 (05) :13893-13905
[9]   Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells [J].
Dai, Chencheng ;
Xu, Pengfei ;
Liu, Siyu ;
Xu, Sujuan ;
Xu, Juan ;
Fu, Ziyi ;
Cao, Jian ;
Lv, Mingming ;
Zhou, Juan ;
Liu, Guangquan ;
Zhang, Huilin ;
Jia, Xuemei .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (05) :1271-1281
[10]   LncRNA TRPM2-AS promotes ovarian cancer progression and cisplatin resistance by sponging miR-138-5p to release SDC3 mRNA [J].
Ding, Yi ;
Tan, Xiangyu ;
Abasi, Abuduyilimu ;
Dai, Yun ;
Wu, Ruxing ;
Zhang, Tao ;
Li, Kexin ;
Yan, Miao ;
Huang, Xiaoyuan .
AGING-US, 2021, 13 (05) :6832-6848